EKGYX | SFCWX | EKGYX / SFCWX | |
Total Expense Ratio | 1.40 | 0.65 | 215% |
Annual Report Gross Expense Ratio | 1.48 | 0.65 | 228% |
Fund Existence | 29 years | 9 years | - |
Gain YTD | 2.021 | 9.923 | 20% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 1000000 | 1000000 | 100% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 119M | 80.3B | 0% |
Annual Yield % from dividends | 0.23 | 0.94 | 24% |
Returns for 1 year | -0.82 | 10.67 | -8% |
Returns for 3 years | 0.94 | 22.71 | 4% |
Returns for 5 years | -0.30 | 17.32 | -2% |
Returns for 10 years | 2.25 | N/A | - |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
FCEF | 22.61 | 0.04 | +0.16% |
First Trust Income Opportunity ETF | |||
MNTL | 23.80 | N/A | N/A |
Tema Neuroscience and Mental Health ETF | |||
FDEV | 32.89 | -0.02 | -0.06% |
Fidelity International Multifactor ETF | |||
TGRW | 44.10 | -0.07 | -0.15% |
T. Rowe Price Growth Stock ETF | |||
VXF | 200.38 | -0.52 | -0.26% |
Vanguard Extended Market ETF |